Literature DB >> 19556835

The hippocampus and nucleus accumbens as potential therapeutic targets for neurosurgical intervention in schizophrenia.

Charles B Mikell1, Guy M McKhann, Solomon Segal, Robert A McGovern, Matthew B Wallenstein, Holly Moore.   

Abstract

Schizophrenia is a chronic and disabling psychiatric illness that is often refractory to treatment. Psychotic symptoms (e.g. hallucinations and delusions) in schizophrenia are reliably correlated with excess dopamine levels in the striatum, and have more recently been related to excess metabolic activity in the hippocampus. Multiple lines of evidence suggest that aberrantly high hippocampal activity may, via hippocampal connections with the limbic basal ganglia, drive excessive dopamine release into the striatum. In the present paper, we hypothesize that inhibition or stabilization of neural activity with high-frequency electrical stimulation of the hippocampus or nucleus accumbens, through different mechanisms, would treat the positive symptoms of schizophrenia. Thus, we suggest a direction for further experimentation aimed at developing neurosurgical therapeutic approaches for this devastating disease. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19556835      PMCID: PMC2836942          DOI: 10.1159/000225979

Source DB:  PubMed          Journal:  Stereotact Funct Neurosurg        ISSN: 1011-6125            Impact factor:   1.875


  77 in total

Review 1.  The effectiveness criterion: balancing efficacy against the risks of weight gain.

Authors:  Leslie Citrome
Journal:  J Clin Psychiatry       Date:  2007       Impact factor: 4.384

2.  Predicting inpatient suicides and suicide attempts by using clinical routine data?

Authors:  Tanja Neuner; Rita Schmid; Manfred Wolfersdorf; Hermann Spiessl
Journal:  Gen Hosp Psychiatry       Date:  2008 Jul-Aug       Impact factor: 3.238

Review 3.  Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex.

Authors:  Satoshi Ikemoto
Journal:  Brain Res Rev       Date:  2007-05-17

4.  Internal pallidal and thalamic stimulation in patients with Tourette syndrome.

Authors:  Marie-Laure Welter; Luc Mallet; Jean-Luc Houeto; Carine Karachi; Virginie Czernecki; Philippe Cornu; Soledad Navarro; Bernard Pidoux; Didier Dormont; Eric Bardinet; Jérôme Yelnik; Philippe Damier; Yves Agid
Journal:  Arch Neurol       Date:  2008-07

Review 5.  Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic.

Authors:  Kerry J Ressler; Helen S Mayberg
Journal:  Nat Neurosci       Date:  2007-09       Impact factor: 24.884

6.  Prospective randomized double-blind trial of bilateral thalamic deep brain stimulation in adults with Tourette syndrome.

Authors:  Robert J Maciunas; Brian N Maddux; David E Riley; Christina M Whitney; Mike R Schoenberg; Paula J Ogrocki; Jeffrey M Albert; Deborah J Gould
Journal:  J Neurosurg       Date:  2007-11       Impact factor: 5.115

Review 7.  Schizophrenia, "just the facts" what we know in 2008. 2. Epidemiology and etiology.

Authors:  Rajiv Tandon; Matcheri S Keshavan; Henry A Nasrallah
Journal:  Schizophr Res       Date:  2008-06-02       Impact factor: 4.939

8.  BOLD responses reflecting dopaminergic signals in the human ventral tegmental area.

Authors:  Kimberlee D'Ardenne; Samuel M McClure; Leigh E Nystrom; Jonathan D Cohen
Journal:  Science       Date:  2008-02-29       Impact factor: 47.728

9.  Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression.

Authors:  Thomas E Schlaepfer; Michael X Cohen; Caroline Frick; Markus Kosel; Daniela Brodesser; Nikolai Axmacher; Alexius Young Joe; Martina Kreft; Doris Lenartz; Volker Sturm
Journal:  Neuropsychopharmacology       Date:  2007-04-11       Impact factor: 7.853

10.  Chronic deep brain stimulation in the rat nucleus accumbens and its effect on morphine reinforcement.

Authors:  Hong-Yu Liu; Jie Jin; Jing-Shi Tang; Wei-Xin Sun; Hong Jia; Xin-Ping Yang; Jian-Mei Cui; Chen-Guang Wang
Journal:  Addict Biol       Date:  2008-03       Impact factor: 4.280

View more
  30 in total

1.  Neurological surgery at the National Institutes of Health.

Authors:  Gautam U Mehta; John D Heiss; John K Park; Ashok R Asthagiri; Kareem A Zaghloul; Russell R Lonser
Journal:  World Neurosurg       Date:  2010-07       Impact factor: 2.104

Review 2.  Stereotactic implantation of deep brain stimulation electrodes: a review of technical systems, methods and emerging tools.

Authors:  Simone Hemm; Karin Wårdell
Journal:  Med Biol Eng Comput       Date:  2010-06-02       Impact factor: 2.602

Review 3.  Mechanisms of deep brain stimulation.

Authors:  Todd M Herrington; Jennifer J Cheng; Emad N Eskandar
Journal:  J Neurophysiol       Date:  2015-10-28       Impact factor: 2.714

4.  Anatomy of the human nucleus accumbens: a combined morphometric study.

Authors:  Ioannis Mavridis; Efstathios Boviatsis; Sophia Anagnostopoulou
Journal:  Surg Radiol Anat       Date:  2011-01-04       Impact factor: 1.246

5.  Deep brain stimulation improves behavior and modulates neural circuits in a rodent model of schizophrenia.

Authors:  Lior Bikovsky; Ravit Hadar; María Luisa Soto-Montenegro; Julia Klein; Ina Weiner; Manuel Desco; Javier Pascau; Christine Winter; Clement Hamani
Journal:  Exp Neurol       Date:  2016-06-11       Impact factor: 5.330

6.  Deletion of adenosine A2A receptors from astrocytes disrupts glutamate homeostasis leading to psychomotor and cognitive impairment: relevance to schizophrenia.

Authors:  Marco Matos; Hai-Ying Shen; Elisabete Augusto; Yumei Wang; Catherine J Wei; Yu Tian Wang; Paula Agostinho; Detlev Boison; Rodrigo A Cunha; Jiang-Fan Chen
Journal:  Biol Psychiatry       Date:  2015-02-27       Impact factor: 13.382

7.  Aripiprazole Increases the PKA Signalling and Expression of the GABAA Receptor and CREB1 in the Nucleus Accumbens of Rats.

Authors:  Bo Pan; Jiamei Lian; Xu-Feng Huang; Chao Deng
Journal:  J Mol Neurosci       Date:  2016-02-19       Impact factor: 3.444

8.  Ketamine induced converged synchronous gamma oscillations in the cortico-basal ganglia network of nonhuman primates.

Authors:  Maya Slovik; Boris Rosin; Shay Moshel; Rea Mitelman; Eitan Schechtman; Renana Eitan; Aeyal Raz; Hagai Bergman
Journal:  J Neurophysiol       Date:  2017-05-03       Impact factor: 2.714

9.  Amotivation is associated with smaller ventral striatum volumes in older patients with schizophrenia.

Authors:  Fernando Caravaggio; Gagan Fervaha; Yusuke Iwata; Eric Plitman; Jun Ku Chung; Shinichiro Nakajima; Wanna Mar; Philip Gerretsen; Julia Kim; M Mallar Chakravarty; Benoit Mulsant; Bruce Pollock; David Mamo; Gary Remington; Ariel Graff-Guerrero
Journal:  Int J Geriatr Psychiatry       Date:  2017-11-07       Impact factor: 3.485

Review 10.  A Review of Oxytocin's Effects on the Positive, Negative, and Cognitive Domains of Schizophrenia.

Authors:  David Feifel; Paul D Shilling; Kai MacDonald
Journal:  Biol Psychiatry       Date:  2015-08-13       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.